本页面由Tiger Trade Technology Pte. Ltd.提供服务

Chemomab Therapeutics Ltd.

1.83
-0.0800-4.19%
盘后1.850.0200+1.09%16:24 EST
成交量:3.45万
成交额:6.40万
市值:1,126.39万
市盈率:-1.09
高:1.99
开:1.99
低:1.75
收:1.91
52周最高:6.14
52周最低:1.35
股本:615.51万
流通股本:500.64万
量比:0.22
换手率:0.69%
股息:- -
股息率:- -
每股收益(TTM):-1.6725
每股收益(LYR):-3.1071
净资产收益率:-73.21%
总资产收益率:-40.61%
市净率:1.00
市盈率(LYR):-0.59

数据加载中...

2025/04/04

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/29

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/21

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/16

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/04

SEC问询函

Form CORRESP - Correspondence
2024/08/20

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/03/28

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/11

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/02

SEC问询函

Form CORRESP - Correspondence
2023/06/16

重要事件披露

Form 8-K - Current report
2023/06/05

重要事件披露

Form 8-K - Current report
2023/05/20

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/11

重要事件披露

8-K - Current report
2023/03/22

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2023/03/21

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2023/03/20

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/22

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933